Intelligent Investor

Arovella Therapeutics Limited (ASX: ALA) - Announcements

Current share price for ALA : $0.125 0.005 (3.85%)

ASX company news and announcements for Arovella Therapeutics Limited (ALA) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Arovella Therapeutics Limited (ALA) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Arovella Therapeutics Limited (ALA), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Arovella Therapeutics Limited (ALA)

Market Cap ($m) Headline Announcement date/time + Price at ann'ment + Current price + Price
7D Avg
Gain/Loss
$131 Updated Share Trading Policy 1 May 2024 11:38AM $0.120 $0.125 $0.120 risen by 4.17%
$131 Quarterly Activities/Appendix 4C Cash Flow Report 30 Apr 2024 9:51AM $0.120 $0.125 $0.120 risen by 4.17%
$131 Proposed issue of securities - ALA 23 Apr 2024 1:41PM $0.115 $0.125 $0.120 risen by 8.70%
$131 Notice of Extraordinary General Meeting/Proxy Form 23 Apr 2024 1:26PM $0.115 $0.125 $0.120 risen by 8.70%
$131 Notification regarding unquoted securities - ALA 10 Apr 2024 1:51PM $0.113 $0.125 $0.120 risen by 11.11%
$131 Arovella presents ALA-101 data at AACR 9 Apr 2024 8:56AM $0.110 $0.125 $0.120 risen by 13.64%
$131 Notice Under Section 708A 4 Apr 2024 11:04AM $0.120 $0.125 $0.120 risen by 4.17%
$131 Application for quotation of securities - ALA 4 Apr 2024 10:45AM $0.123 $0.125 $0.120 risen by 2.04%
$131 Prof Gianpietro Dotti appointed to Scientific Advisory Board 3 Apr 2024 10:18AM $0.125 $0.125 $0.120 fallen by 0%
$131 Change of Director's Interest Notice - GP 3 Apr 2024 8:28AM $0.115 $0.125 $0.120 risen by 8.70%
$131 Change of Director's Interest Notice - TD 2 Apr 2024 8:31AM $0.150 $0.125 $0.120 fallen by 16.67%
$131 Change of Director's Interest Notice - MB 28 Mar 2024 9:49AM $0.145 $0.125 $0.120 fallen by 13.79%
$131 Arovella to present at AACR annual meeting 27 Mar 2024 10:55AM $0.130 $0.125 $0.120 fallen by 3.85%
$131 Investor Presentation 26 Mar 2024 9:38AM $0.130 $0.125 $0.120 fallen by 3.85%
$131 Proposed issue of securities - ALA 26 Mar 2024 9:38AM $0.130 $0.125 $0.120 fallen by 3.85%
$131 Proposed issue of securities - ALA 26 Mar 2024 9:38AM $0.130 $0.125 $0.120 fallen by 3.85%
$131 Arovella Completes $12.5M Placement - Funded to Phase 1 Data 26 Mar 2024 9:38AM $0.130 $0.125 $0.120 fallen by 3.85%
$131 Trading Halt 22 Mar 2024 9:56AM $0.130 $0.125 $0.120 fallen by 3.85%
$131 Pause in Trading 22 Mar 2024 9:50AM $0.130 $0.125 $0.120 fallen by 3.85%
$131 NWR Virtual Healthcare Conference Presentation 20 Mar 2024 9:11AM $0.155 $0.125 $0.120 fallen by 19.35%
$131 ALA-101 and onCARlytics collaboration update 20 Mar 2024 8:52AM $0.155 $0.125 $0.120 fallen by 19.35%
$131 Arovella to present at NWR virtual healthcare conference 19 Mar 2024 10:23AM $0.150 $0.125 $0.120 fallen by 16.67%
$131 Spark Plus Singapore Healthcare Day Presentation 14 Mar 2024 11:16AM $0.155 $0.125 $0.120 fallen by 19.35%
$131 Release of Shares from Escrow 1 Mar 2024 8:35AM $0.165 $0.125 $0.120 fallen by 24.24%
$131 Notice Under Section 708A 29 Feb 2024 10:29AM $0.175 $0.125 $0.120 fallen by 28.57%

1 - 25 of 425 results

Page 1 of 17

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© 2017 Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.